How the immune system shapes atherosclerosis: roles of innate and adaptive immunity

P Roy, M Orecchioni, K Ley - Nature Reviews Immunology, 2022 - nature.com
Atherosclerosis is the root cause of many cardiovascular diseases. Extensive research in
preclinical models and emerging evidence in humans have established the crucial roles of …

Macrophages in atherosclerosis regression

TJ Barrett - Arteriosclerosis, thrombosis, and vascular biology, 2020 - Am Heart Assoc
Macrophages play a central role in the development of atherosclerotic cardiovascular
disease (ASCVD), which encompasses coronary artery disease, peripheral artery disease …

Macrophage plasticity and atherosclerosis therapy

P Lin, HH Ji, YJ Li, SD Guo - Frontiers in molecular biosciences, 2021 - frontiersin.org
Atherosclerosis is a chronic disease starting with the entry of monocytes into the
subendothelium and the subsequent differentiation into macrophages. Macrophages are the …

Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression

M Sharma, MP Schlegel, MS Afonso, EJ Brown… - Circulation …, 2020 - Am Heart Assoc
Rationale: Regression of atherosclerosis is an important clinical goal; however, the
pathways that mediate the resolution of atherosclerotic inflammation and reversal of plaques …

Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages

Z An, J Li, J Yu, X Wang, H Gao, W Zhang, Z Wei… - Cell Cycle, 2019 - Taylor & Francis
Here, we sought to explore the underlying role of interleukin (IL)-8 in neutrophil extracellular
traps (NETs) formation during atherosclerosis (AS). The concentration of pro-inflammatory …

[HTML][HTML] GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

E Guttman-Yassky, AB Pavel, L Zhou… - Journal of Allergy and …, 2019 - Elsevier
Background GBR 830 is a humanized mAb against OX40, a costimulatory receptor on
activated T cells. OX40 inhibition might have a therapeutic role in T cell–mediated diseases …

Regulatory T cells in ischemic stroke

H Wang, J Ye, L Cui, S Chu, N Chen - Acta Pharmacologica Sinica, 2022 - nature.com
Recent evidence shows that when ischemic stroke (IS) occurs, the BBB would be destructed,
thereby promoting the immune cells to migrate into the brain, suggesting that the immune …

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease

M Lacy, C Bürger, A Shami, M Ahmadsei… - Nature …, 2021 - nature.com
Atherosclerosis is a major underlying cause of cardiovascular disease. Previous studies
showed that inhibition of the co-stimulatory CD40 ligand (CD40L)-CD40 signaling axis …

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial

HE Gendelman, Y Zhang, P Santamaria… - NPJ Parkinson's …, 2017 - nature.com
A potential therapeutic role for immune transformation in Parkinson's disease evolves from
more than a decade of animal investigations demonstrating regulatory T cell (Treg) …

Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages

H Zhang, S Ge, B Ni, K He, P Zhu, X Wu, Y Shao - Autophagy, 2021 - Taylor & Francis
Dysfunction of macroautophagy/autophagy in macrophages contributes to atherosclerosis.
Impaired autophagy-lysosomal degradation system leads to lipid accumulation, facilitating …